ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 2 of 35 for:    Not yet recruiting Studies | Psychiatric

Internet Gaming Disorder and Psychiatric Disorder (IGDPD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03366948
Recruitment Status : Not yet recruiting
First Posted : December 8, 2017
Last Update Posted : December 8, 2017
Sponsor:
Information provided by (Responsible Party):
Hospices Civils de Lyon

Brief Summary:

The fifth edition of the Diagnostic and Statistical Manual of Mental Disorders (DSM-5) recently identified Internet gaming disorder as a new potential psychiatric disorder which need further research. Several studies showed the important prevalence of psychiatric disorders among patients suffering from internet gaming disorder. Investigators hypothesize that on an other side the prevalence of internet gaming disorder among patients suffering from psychiatric disorders shall be high but it has never been studied yet.

The main goal of this trial is to examine the prevalence of internet gaming disorder using the Internet Gaming Disorder Test-10 (IGDT-10) among inpatient aged from 12 to 17 of 4 psychiatric units of French region Auvergne-Rhône-Alpes.

Secondary goals will be to assess a parental version of the IGDT-10 (IGDT-10-P) and to compare the two versions.

IGDT-10 will be passed during 6 months to every inpatient and IGDT-10-P to their parents within the 21 first days of the hospitalisation.


Condition or disease Intervention/treatment
Psychiatric Disorder Other: IGDT-10 self-administered questionnaire

Study Type : Observational
Estimated Enrollment : 300 participants
Observational Model: Other
Time Perspective: Prospective
Official Title: Internet Gaming Disorder Prevalence of Teenager Psychiatric Inpatient of 4 Psychiatric Units of French Region Auvergne-Rhône-Alpes
Estimated Study Start Date : January 2018
Estimated Primary Completion Date : June 2018
Estimated Study Completion Date : June 2018

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Mental Disorders


Intervention Details:
  • Other: IGDT-10 self-administered questionnaire

    Patients and their parents will answer the French version of the IGDT-10 self-administered questionnaire (IGDT-10-P in the parents 'questionnaire).

    The IGDT-10 is a self-administered questionnaire based on DSM-5 internet gaming disorder criteria and the IGDT-10-P is a parental version specially adapted from the IGDT-10 for this study.



Primary Outcome Measures :
  1. Proportion of patients with a IGDT-10 score above 5 [ Time Frame: In the first 21 days after the admission in the psychiatric unit. ]
    The 10-item Internet Gaming Disorder is a 10 dichotomous items self-assessment scale corresponding to the 9 diagnostic criteria of the DSM-5 IGD (the last item is split in two but should only be counted once). In agreement with DSM-5, a diagnosis of IGD is considered positive if 5 criteria are validated. Each criterion is filled by the patient as "never", "sometimes" or "often", a criterion is validated if it is reported to be present "often" in the last 12 months according to DSM-5 guidelines. The Ten-Item Internet Gaming Disorder Test (IGDT-10) by Király et al. was validated in English for a population of 14 to 64 years10 then in French in adults by Laconi et al.29. This is a valid and reliable scale.



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   12 Years to 17 Years   (Child)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
Patient aged from 12 to 17 of 4 psychiatric units of French region Auvergne-Rhône-Alpes and their parents.
Criteria

Inclusion Criteria:

  • Patient aged from 12 to 17
  • Parents of the patient, older than 18 years old
  • Patients hospitalized in 4 psychiatric units of French region Auvergne-Rhône-Alpes

Exclusion Criteria:

  • Patient and/or theirs parents are not fluent in French
  • Intellectual deficit (known intelligence quotient below 70)
  • Behaviour disorder making impossible to pass the questionnaire

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03366948


Contacts
Contact: Mohamed SAOUD, Pr 04 72 11 80 64 ext +33 mohamed.saoud@chu-lyon.fr

Locations
France
Service de psychiatrie adulte Hôpital Pierre Wertheimer-GHE Not yet recruiting
Bron, France, 69677
Contact: Mohamed SAOUD, Pr    04 72 11 80 64 ext +33    mohamed.saoud@chu-lyon.fr   
Principal Investigator: Mohamed SAOUD, Pr         
Sponsors and Collaborators
Hospices Civils de Lyon

Responsible Party: Hospices Civils de Lyon
ClinicalTrials.gov Identifier: NCT03366948     History of Changes
Other Study ID Numbers: 69HCL17_0685
First Posted: December 8, 2017    Key Record Dates
Last Update Posted: December 8, 2017
Last Verified: December 2017
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No

Additional relevant MeSH terms:
Disease
Mental Disorders
Problem Behavior
Pathologic Processes
Behavioral Symptoms